The store will not work correctly when cookies are disabled.
2-((5-(4-chloro-3-methylphenyl)furan-2-yl)methylene)benzo[b]thiophen-3(2H)-one
ID: ALA4777785
PubChem CID: 993867
Max Phase: Preclinical
Molecular Formula: C20H13ClO2S
Molecular Weight: 352.84
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(-c2ccc(/C=C3\Sc4ccccc4C3=O)o2)ccc1Cl
Standard InChI: InChI=1S/C20H13ClO2S/c1-12-10-13(6-8-16(12)21)17-9-7-14(23-17)11-19-20(22)15-4-2-3-5-18(15)24-19/h2-11H,1H3/b19-11-
Standard InChI Key: MBQCPKZENIXIEZ-ODLFYWEKSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
9.9865 -2.9138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9853 -3.7333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6934 -4.1423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6916 -2.5049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4002 -2.9102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4005 -3.7334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1834 -3.9875 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.6671 -3.3214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1830 -2.6556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4353 -1.8784 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4843 -3.3211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8932 -4.0287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5578 -4.7727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1653 -5.3193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8729 -4.9105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7026 -4.1112 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5773 -5.3173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5771 -6.1356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2845 -6.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9926 -6.1335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9889 -5.3121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2808 -4.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6945 -4.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7015 -6.5402 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 2 0
8 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
15 17 1 0
21 23 1 0
20 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 352.84 | Molecular Weight (Monoisotopic): 352.0325 | AlogP: 6.24 | #Rotatable Bonds: 2 |
Polar Surface Area: 30.21 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.42 | CX LogD: 5.42 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.51 | Np Likeness Score: -1.44 |
References
1. Hou X,Sun JP,Ge L,Liang X,Li K,Zhang Y,Fang H. (2020) Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets., 190 [PMID:32078861] [10.1016/j.ejmech.2020.112131] |